Composition
Each scored tablet contains:
Captopril .................................................................................. 25 mg or 50 mg
Inactive ingredients: Microcrystalline cellulose, colloidal silicon dioxide, talc purified, magnesium stearate, lactose D.C. anhydrous, sodium starch glycolate.

Therapeutic Indications
Hypertension:
CAPOTRIL is indicated for the treatment of hypertension.
Heart Failure:
CAPOTRIL is indicated for the treatment of chronic heart failure with reduction of systolic ventricular function, in combination with diuretics and, when appropriate, digitalis and beta-blockers.
Myocardial Infarction:
Short-term (4 weeks) treatment:
CAPOTRIL is indicated in any clinically stable patient within the first 24 hours of an infarction.
Long-term prevention of symptomatic heart failure:
CAPOTRIL is indicated in clinically stable patients with asymptomatic left ventricular dysfunction (ejection fraction > 40%).
Type I Diabetic Nephropathy:
CAPOTRIL is indicated for the treatment of macroproteinuric diabetic nephropathy in patients with type I diabetes